GB201910607D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB201910607D0
GB201910607D0 GBGB1910607.9A GB201910607A GB201910607D0 GB 201910607 D0 GB201910607 D0 GB 201910607D0 GB 201910607 A GB201910607 A GB 201910607A GB 201910607 D0 GB201910607 D0 GB 201910607D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1910607.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enterprise Therapeutics Ltd
Original Assignee
Enterprise Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enterprise Therapeutics Ltd filed Critical Enterprise Therapeutics Ltd
Priority to GBGB1910607.9A priority Critical patent/GB201910607D0/en
Publication of GB201910607D0 publication Critical patent/GB201910607D0/en
Priority to PCT/GB2020/051778 priority patent/WO2021014166A1/en
Priority to CR20220072A priority patent/CR20220072A/en
Priority to CA3145120A priority patent/CA3145120A1/en
Priority to EP20751234.4A priority patent/EP4003516A1/en
Priority to KR1020227006371A priority patent/KR20220063162A/en
Priority to BR112022001164A priority patent/BR112022001164A2/en
Priority to JP2022504089A priority patent/JP2022541311A/en
Priority to CN202080053192.6A priority patent/CN114616226A/en
Priority to PE2022000119A priority patent/PE20221441A1/en
Priority to AU2020317036A priority patent/AU2020317036A1/en
Priority to MX2022000841A priority patent/MX2022000841A/en
Priority to US17/581,504 priority patent/US20220235006A1/en
Priority to CL2022000147A priority patent/CL2022000147A1/en
Priority to IL290035A priority patent/IL290035A/en
Priority to CONC2022/0002022A priority patent/CO2022002022A2/en
Ceased legal-status Critical Current

Links

GBGB1910607.9A 2019-07-24 2019-07-24 Compounds Ceased GB201910607D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB1910607.9A GB201910607D0 (en) 2019-07-24 2019-07-24 Compounds
MX2022000841A MX2022000841A (en) 2019-07-24 2020-07-24 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions.
BR112022001164A BR112022001164A2 (en) 2019-07-24 2020-07-24 Compound, use of a compound, method for the treatment or prophylaxis of diseases, compound for use and pharmaceutical composition
CN202080053192.6A CN114616226A (en) 2019-07-24 2020-07-24 Pyridine derivatives as TMEM16A modulators for the treatment of respiratory disorders
CA3145120A CA3145120A1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions
EP20751234.4A EP4003516A1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions
KR1020227006371A KR20220063162A (en) 2019-07-24 2020-07-24 Pyridine derivatives as TMEM16A modulators for use in the treatment of respiratory conditions
PCT/GB2020/051778 WO2021014166A1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions
JP2022504089A JP2022541311A (en) 2019-07-24 2020-07-24 Pyridine derivatives as TMEM16A modulators for use in treating respiratory symptoms
CR20220072A CR20220072A (en) 2019-07-24 2020-07-24 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions
PE2022000119A PE20221441A1 (en) 2019-07-24 2020-07-24 PYRIDINE DERIVATIVES AS TMEM16A MODULATORS FOR USE IN THE TREATMENT OF RESPIRATORY DISEASES
AU2020317036A AU2020317036A1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as TMEM16A modulators for use in the treatment of respiratory conditions
CL2022000147A CL2022000147A1 (en) 2019-07-24 2022-01-21 Pyridine derivatives as modulators of tmem16a for use in the treatment of respiratory conditions.
US17/581,504 US20220235006A1 (en) 2019-07-24 2022-01-21 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions
IL290035A IL290035A (en) 2019-07-24 2022-01-23 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions
CONC2022/0002022A CO2022002022A2 (en) 2019-07-24 2022-02-24 Pyridine derivatives as modulators of tmem16a for use in the treatment of respiratory conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1910607.9A GB201910607D0 (en) 2019-07-24 2019-07-24 Compounds

Publications (1)

Publication Number Publication Date
GB201910607D0 true GB201910607D0 (en) 2019-09-04

Family

ID=67839711

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1910607.9A Ceased GB201910607D0 (en) 2019-07-24 2019-07-24 Compounds

Country Status (1)

Country Link
GB (1) GB201910607D0 (en)

Similar Documents

Publication Publication Date Title
IL292753A (en) Compounds
IL289463A (en) Gipr-agonist compounds
GB201905721D0 (en) Compounds
GB201916915D0 (en) Compounds
GB201910305D0 (en) Compounds
GB201908536D0 (en) Compounds
GB201908171D0 (en) Compounds
GB201910304D0 (en) Compounds
GB201908095D0 (en) Carboxy-MIDA-boronate compounds
GB201919205D0 (en) Compounds
GB201918761D0 (en) Compounds
GB201918424D0 (en) Compounds
GB201917895D0 (en) Compounds
GB201917893D0 (en) Compounds
GB201917891D0 (en) Compounds
GB201916847D0 (en) Compounds
GB201916597D0 (en) Compounds
GB201916572D0 (en) Compounds
GB201916595D0 (en) Compounds
GB201916142D0 (en) Compounds
GB201914208D0 (en) Compounds
GB201913633D0 (en) Compounds
GB201913541D0 (en) Compounds
GB201912850D0 (en) Compounds
GB201911848D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)